Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 55154-4759

5 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55154-4759). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1

Figure 1
A cumulative response curve chart comparing the percentage reduction in CPS rate for patients treated with Divalproex Sodium delayed-release tablets versus placebo. The x-axis represents the percentage of patients, and the y-axis shows the percent reduction in CPS rate, with directions for improvement and worsening indicated on the right side.*
FDA Label Image

Figure 2

Figure 2
A cumulative distribution graph depicting the percentage reduction in CPS rate relative to the percentage of patients for high dose and low dose treatments. The y-axis ranges from -100% to 100% indicating worsening to improvement, while the x-axis shows patient percentage from 100 to 0. High dose is shown with a solid line, and low dose with a dashed line.*
FDA Label Image

Guide

Guide
An illustrated instructional diagram demonstrating the proper method for opening and using a large capsule containing coated pellets of Divalproex Sodium 125 mg. The four-step guide shows holding and twisting the capsule to open, sprinkling the pellets onto soft food like applesauce or pudding, and ensuring the mixture is swallowed immediately without chewing, with advice on handling spills and storage.*
FDA Label Image

Structure

Structure
Chemical structure of divalproex sodium, shown as a polymeric structure with sodium ion and multiple carboxylate groups connected to hydrocarbon chains representing valproic acid moieties.*
FDA Label Image

B4e8a22e Edba 4424 B2b3 7582968c88e5 00

B4e8a22e Edba 4424 B2b3 7582968c88e5 00
Label for Divalproex Sodium 125 mg delayed-release capsules, USP, containing valproic acid activity. The package contains 10 capsules. It includes instructions on storage, dosage, and warnings, specifying it is an RX-only medication intended for institutional use, distributed by Cardinal Health and American Health Packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.